Veru, EyePoint Pharmaceuticals, Sintx Technologies among healthcare movers [Seeking Alpha]
NRX Pharmaceuticals, Inc. (NRXP)
Company Research
Source: Seeking Alpha
Intelligent Bio Solutions ( INBS Losers: NRx Pharmaceuticals ( NRXP INVO Bioscience ( INVO ProKidney ( PROK Veru ( VERU EyePoint Pharmaceuticals ( EYPT S&P 500 Health Care Sector to 1613.26. Health Care Equipment & Services to 1893.99. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is to 1310.58. Recommended For You More Trending News Recommended For You More Trending News Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
NRXP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NRXP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NRXP alerts
High impacting NRX Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
NRXP
News
- NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression [Yahoo! Finance]Yahoo! Finance
- NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar DepressionPR Newswire
- NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price RequirementPR Newswire
NRXP
Earnings
- 11/13/23 - Beat
NRXP
Sec Filings
- 4/30/24 - Form 8-K
- 4/29/24 - Form 10-K/A
- 4/19/24 - Form 8-K
- NRXP's page on the SEC website